Capital follows vitality. Here is where the global longevity, investment, and high-performance ecosystem meets next.

The field has moved fast. Not long ago longevity was treated as a curiosity; now Longevity's a real investment category, on track to reach $67B by 2035. That shift is the thing worth paying attention to. The good companies aren't selling immortality. They're going after healthspan, treating aging as a root cause, and measuring themselves against clinical results.

Executive Summary The Event: Global venture capital firm QAI Ventures launches Singapore’s inaugural Quantum Accelerator in partnership with Enterprise Singapore, deploying an initial SGD 300,000 capital package per deep-tech venture. The Thesis: Quantum computing represents the definitive backend infrastructure for the luxury longevity economy. The transition from basic discovery to biological engineering requires processing capacities capable of bypassing legacy lab

Executive Summary The Event: ŌURA acquires Galen AI, a Y Combinator-backed startup specializing in AI-powered aggregation of medical records, lab results, medications, and wearable data into a unified interface. The Thesis: The longevity economy is shifting from wearable devices to integrated Health Intelligence Platforms — where AI, biometrics, and longitudinal clinical data converge into a continuous operating system for preventive health.

L Catterton, the private equity fund backed by LVMH and Groupe Arnault, has invested up to US$5 million in WTHN, the New York-based brand that modernises Traditional Chinese Medicine (TCM) through a clean, design-led luxury model.